Design Therapeutics Inc (DSGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -22,898 | -11,105 | -66,862 | -55,020 | -39,231 |
| Depreciation Amortization | -3,010 | -1,588 | -5,547 | -3,849 | -2,277 |
| Other Working Capital | -4,282 | -2,934 | 728 | 2,715 | 3,115 |
| Other Operating Activity | 6,491 | 3,188 | 13,121 | 10,392 | 7,165 |
| Operating Cash Flow | $-23,699 | $-12,439 | $-58,560 | $-45,762 | $-31,228 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 48,305 | 20,811 | 52,792 | 47,210 | 31,891 |
| PPE Investments | -356 | -195 | -256 | -229 | -176 |
| Investing Cash Flow | $47,949 | $20,616 | $52,536 | $46,981 | $31,715 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 249 | 20 | 724 | 223 | 210 |
| Financing Cash Flow | $249 | $20 | $724 | $223 | $210 |
| Beginning Cash Position | 21,200 | 21,200 | 26,500 | 26,500 | 26,500 |
| End Cash Position | 45,699 | 29,397 | 21,200 | 27,942 | 27,197 |
| Net Cash Flow | $24,499 | $8,197 | $-5,300 | $1,442 | $697 |
| Free Cash Flow | |||||
| Operating Cash Flow | -23,699 | -12,439 | -58,560 | -45,762 | -31,228 |
| Capital Expenditure | -356 | -195 | -256 | -229 | -176 |
| Free Cash Flow | -24,055 | -12,634 | -58,816 | -45,991 | -31,404 |